Reference health
Low NT-proBNP levels: An early sign for the diagnosis of ischemic heart failure
27/27 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 27 checked references that resolve
resolves10.1093/eurheartj/ehs104
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
resolves10.1093/eurheartj/ehi631
NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients
resolves10.1056/NEJMoa020233
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
resolves10.1001/jama.288.17.2144
Pathophysiological Characterization of Isolated Diastolic Heart Failure in Comparison to Systolic Heart Failure
resolves10.1186/1471-2261-9-2
Characteristics of acute congestive heart failure with normal ejection fraction and less elevated B-type natriuretic peptide
resolves10.1016/j.ahj.2005.06.045
Use of B-type natriuretic peptide in the detection of myocardial ischemia
resolves10.1016/j.jacc.2005.03.050
The Efficacy of Brain Natriuretic Peptide Levels in Differentiating Constrictive Pericarditis From Restrictive Cardiomyopathy
resolves10.1016/j.ejheart.2008.08.005
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
resolves10.1016/S0735-1097(00)00804-4
Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction
resolves10.1136/hrt.2004.037762
Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure
resolves10.1002/clc.20075
Troponin, B‐type natriuretic peptides and outcomes in severe heart failure: Differences between ischemic and dilated cardiomyopathies
resolves10.1016/S0735-1097(03)00405-4
Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction
resolves10.1016/j.amjcard.2003.07.010
Brain natriuretic peptide is elevated in outpatients with atrial fibrillation
resolves10.1016/S0735-1097(02)02059-4
Plasma brain natriuretic peptide concentration: impact of age and gender
resolves10.1016/j.jacc.2005.05.057
Impact of Atrial Fibrillation on the Diagnostic Performance of B-Type Natriuretic Peptide Concentration in Dyspneic Patients
resolves10.1016/S0002-9149(02)02464-5
Impact of age and sex on plasma natriuretic peptide levels in healthy adults
resolves10.1016/j.jacc.2003.10.066
Obesity and suppressed B-type natriuretic peptide levels in heart failure
resolves10.1016/j.jacc.2005.08.050
B-Type Natriuretic Peptide Levels in Obese Patients With Advanced Heart Failure
resolves10.1016/S0002-8703(98)70041-9
Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
resolves10.1016/j.jacc.2004.07.057
Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia
resolves10.1161/01.CIR.88.1.82
Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.
resolves10.1016/S0735-1097(00)01157-8
A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study
The 2 references without a DOI — listed, not checked
no DOI — not checkedHow B-type natriuretic peptide (BNP) and body weight changes vary in heart failure with preserved ejection fraction compared with reduced ejection fraction: secondary results of the HABIT (HF Assessment with BNP in the Home) Trial
no DOI — not checkedQuantifying cardiac hemodynamic stress and cardiomyocyte damage in ischemic and nonischemic acute heart failure
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.ijcard.2016.11.139"><img src="https://citestamp.com/citestamped/10.1016/j.ijcard.2016.11.139/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.ijcard.2016.11.139)